These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22594958)

  • 1. Patient satisfaction with topical ocular hypotensives.
    Kerr NM; Patel HY; Chew SS; Ali NQ; Eady EK; Danesh-Meyer HV
    Clin Exp Ophthalmol; 2013; 41(1):27-35. PubMed ID: 22594958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients.
    Day DG; Sharpe ED; Atkinson MJ; Stewart JA; Stewart WC
    Eye (Lond); 2006 May; 20(5):583-90. PubMed ID: 15933751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP).
    Atkinson MJ; Stewart WC; Fain JM; Stewart JA; Dhawan R; Mozaffari E; Lohs J
    Health Qual Life Outcomes; 2003 Nov; 1():67. PubMed ID: 14617372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vision related quality of life and topical glaucoma treatment side effects.
    Nordmann JP; Auzanneau N; Ricard S; Berdeaux G
    Health Qual Life Outcomes; 2003 Dec; 1():75. PubMed ID: 14667241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of eye drop administration technique in patients with glaucoma or ocular hypertension.
    Schwartz GF; Hollander DA; Williams JM
    Curr Med Res Opin; 2013 Nov; 29(11):1515-22. PubMed ID: 24006861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
    Fechtner RD; Godfrey DG; Budenz D; Stewart JA; Stewart WC; Jasek MC
    Cornea; 2010 Jun; 29(6):618-21. PubMed ID: 20386433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication.
    Salyani A; Birt C
    Can J Ophthalmol; 2005 Apr; 40(2):170-4. PubMed ID: 16049530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An objective evaluation of eyedrop instillation in patients with glaucoma.
    Stone JL; Robin AL; Novack GD; Covert DW; Cagle GD
    Arch Ophthalmol; 2009 Jun; 127(6):732-6. PubMed ID: 19506189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data.
    Dasgupta S; Oates V; Bookhart BK; Vaziri B; Schwartz GF; Mozaffari E
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S255-61. PubMed ID: 12188168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial.
    Lamoureux EL; Mcintosh R; Constantinou M; Fenwick EK; Xie J; Casson R; Finkelstein E; Goldberg I; Healey P; Thomas R; Ang GS; Pesudovs K; Crowston J
    Trials; 2015 Sep; 16():406. PubMed ID: 26362541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of ocular surface disease in patients with glaucoma.
    Mathews PM; Ramulu PY; Friedman DS; Utine CA; Akpek EK
    Ophthalmology; 2013 Nov; 120(11):2241-8. PubMed ID: 23714318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nationwide survey of factors influencing adherence to ocular hypotensive eyedrops in Japan.
    Tsumura T; Kashiwagi K; Suzuki Y; Yoshikawa K; Suzumura H; Maeda T; Takeda R; Saito H; Araie M
    Int Ophthalmol; 2019 Feb; 39(2):375-383. PubMed ID: 29330811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival and corneal sensitivity in patients under topical antiglaucoma treatment.
    Romero-Díaz de León L; Morales-León JE; Ledesma-Gil J; Navas A
    Int Ophthalmol; 2016 Jun; 36(3):299-303. PubMed ID: 26272426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
    Hermann MM; Bron AM; Creuzot-Garcher CP; Diestelhorst M
    J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morning dosing of once-daily glaucoma medication is more convenient and may lead to greater adherence than evening dosing.
    Ford BA; Gooi M; Carlsson A; Crichton AC
    J Glaucoma; 2013 Jan; 22(1):1-4. PubMed ID: 21946541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users.
    Ramdas WD; van der Velde N; van der Cammen TJ; Wolfs RC
    Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1235-41. PubMed ID: 19452162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical therapies for glaucoma and ocular hypertension: an update on current practice.
    Rouland JF
    Eur J Ophthalmol; 2003 Jul; 13 Suppl 4():S1-4. PubMed ID: 14628758
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
    Hwang DK; Liu CJ; Pu CY; Chou YJ; Chou P
    JAMA Ophthalmol; 2014 Dec; 132(12):1446-52. PubMed ID: 25211300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.